Inspire Medical Systems Inc (INSP)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 58,453 | -19,906 | -44,268 | -41,970 | -57,088 |
| Revenue | US$ in thousands | 802,804 | 624,799 | 406,179 | 231,266 | 113,364 |
| Pretax margin | 7.28% | -3.19% | -10.90% | -18.15% | -50.36% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $58,453K ÷ $802,804K
= 7.28%
The pretax margin of Inspire Medical Systems Inc has been showing a positive trend over the years. Starting at a low of -50.36% on December 31, 2020, the company managed to significantly improve its profitability, reaching -18.15% by December 31, 2021. This positive momentum continued, with a further reduction in pretax margin to -10.90% by December 31, 2022, and -3.19% by December 31, 2023.
The most notable improvement came by December 31, 2024, where the company achieved a pretax margin of 7.28%, turning a profitability corner with positive after-tax earnings. This upward trend in pretax margin reflects the company's efforts in cost management, revenue growth, and overall operational efficiency, indicating a strengthening financial position and potential for sustained profitability in the future.
Peer comparison
Dec 31, 2024